These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 17119331

  • 1. Long-term erythropoietin therapy decreases CC-chemokine levels and intima-media thickness in hemodialyzed patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Am J Nephrol; 2006; 26(5):497-502. PubMed ID: 17119331
    [Abstract] [Full Text] [Related]

  • 2. Long-term erythropoietin therapy does not affect metalloproteinases and their inhibitor levels, oxidative stress and inflammation in hemodialyzed patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Am J Nephrol; 2007; 27(3):221-5. PubMed ID: 17384500
    [Abstract] [Full Text] [Related]

  • 3. The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients.
    Pawlak K, Mysliwiec M, Pawlak D.
    Thromb Res; 2008; 122(3):328-35. PubMed ID: 18048089
    [Abstract] [Full Text] [Related]

  • 4. Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Nephron Physiol; 2004; 96(4):p105-12. PubMed ID: 15122056
    [Abstract] [Full Text] [Related]

  • 5. [Effect of antiretroviral therapy on carotid intima-media thickness in HIV-infected patients].
    Ferraro S, Paolillo S, Gargiulo M, Costanzo P, Maggi P, Chirianni A, Chiariello M, Filardi PP.
    G Ital Cardiol (Rome); 2009 Sep; 10(9):596-601. PubMed ID: 19891251
    [Abstract] [Full Text] [Related]

  • 6. Circulating beta-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients--role of oxidative stress.
    Pawlak K, Pawlak D, Mysliwiec M.
    Cytokine; 2005 Jul 07; 31(1):18-24. PubMed ID: 15896974
    [Abstract] [Full Text] [Related]

  • 7. Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.
    Adamowicz A, Trafikowska U, Trafikowska A, Zachara B, Manitius J.
    Med Sci Monit; 2002 Mar 07; 8(3):CR202-5. PubMed ID: 11887037
    [Abstract] [Full Text] [Related]

  • 8. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
    Pawlak K, Pawlak D, Mysliwiec M.
    Thromb Res; 2008 Mar 07; 121(6):787-91. PubMed ID: 17869326
    [Abstract] [Full Text] [Related]

  • 9. Influence of haemodialysis on early markers of atherosclerosis.
    Kovacic V, Ljutic D, Dodig J, Radic M, Duplancic D.
    Nephrology (Carlton); 2008 Dec 07; 13(6):472-9. PubMed ID: 18518941
    [Abstract] [Full Text] [Related]

  • 10. Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis.
    Stompór T, Kraśniak A, Sułowicz W, Dembińska-Kieć A, Janda K, Wójcik K, Tabor B, Kowalczyk-Michałek ME, Zdzienicka A, Janusz-Grzybowska E.
    Nephrol Dial Transplant; 2005 Feb 07; 20(2):404-12. PubMed ID: 15618238
    [Abstract] [Full Text] [Related]

  • 11. Kinetics of chemokines in acute myocardial infarction.
    Kobusiak-Prokopowicz M, Orzeszko J, Mazur G, Mysiak A, Orda A, Mazurek W.
    Kardiol Pol; 2005 Apr 07; 62(4):301-14; discussion 315-6. PubMed ID: 15928736
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
    Khosroshahi HT, Shoja MM, Tubbs RS, Estakhri R, Ardalan MR.
    Transplant Proc; 2007 May 07; 39(4):1051-3. PubMed ID: 17524889
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inflammation but not oxidative stress is associated with beta-chemokine levels and prevalence of cardiovascular disease in uraemic patients.
    Pawlak K, Pawlak D, Myśliwiec M.
    Cytokine; 2006 Sep 07; 35(5-6):258-62. PubMed ID: 17070067
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus.
    Hiukka A, Westerbacka J, Leinonen ES, Watanabe H, Wiklund O, Hulten LM, Salonen JT, Tuomainen TP, Yki-Järvinen H, Keech AC, Taskinen MR.
    J Am Coll Cardiol; 2008 Dec 16; 52(25):2190-7. PubMed ID: 19095138
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of functional chemokine receptors (CCR1 and CCR2) on EoL-3 cells: a model system to examine the role of chemokines in cell function.
    Sarau HM, Rush JA, Foley JJ, Brawner ME, Schmidt DB, White JR, Barnette MS.
    J Pharmacol Exp Ther; 1997 Oct 16; 283(1):411-8. PubMed ID: 9336350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.